Eyepoint Pharmaceuticals Inc Market Cap ($32.70 Million)

$32.70 Million USD · Rank #23266

Market Cap & Net Worth: Eyepoint Pharmaceuticals Inc (EYPT)

Eyepoint Pharmaceuticals Inc market cap. Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) has a market capitalization of $32.70 Million ($32.70 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23266 globally and #5090 in its home market, demonstrating a 8.76% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eyepoint Pharmaceuticals Inc's stock price $0.40 by its total outstanding shares 82787220 (82.79 Million). Also see cash efficiency ratio of Eyepoint Pharmaceuticals Inc for how efficiently the company converts equity into cash flow.

Eyepoint Pharmaceuticals Inc Market Cap History (2015–2026)

Eyepoint Pharmaceuticals Inc market cap history from 2015 to 2026. Data shows change from $3.99 Billion to $32.70 Million (-34.06% CAGR). Check today's stock price for Eyepoint Pharmaceuticals Inc for real-time trading data and today's change.

Index Memberships

Eyepoint Pharmaceuticals Inc is a constituent of 3 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.62 Trillion	0.00%	#656 of 976
NASDAQ Composite IXIC	$40.12 Trillion	0.00%	#2181 of 3165
NASDAQ Biotechnology NBI	$1.84 Trillion	0.00%	#249 of 263

Weight: Eyepoint Pharmaceuticals Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Eyepoint Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Eyepoint Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Eyepoint Pharmaceuticals Inc equity growth rate to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

14.25x

Eyepoint Pharmaceuticals Inc's market cap is 14.25 times its annual revenue

Industry average: 4569.38x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2015	$3.99 Billion	$26.57 Million	$6.35 Million	150.21x	628.70x
2016	$1.42 Billion	$1.62 Million	-$21.55 Million	873.87x	N/A
2017	$894.10 Million	$7.54 Million	-$18.48 Million	118.60x	N/A
2018	$1.56 Billion	$2.96 Million	-$53.17 Million	528.43x	N/A
2019	$1.28 Billion	$20.36 Million	-$56.79 Million	63.01x	N/A
2020	$544.74 Million	$34.44 Million	-$45.39 Million	15.82x	N/A
2021	$1.01 Billion	$36.94 Million	-$58.42 Million	27.43x	N/A
2022	$289.76 Million	$41.40 Million	-$102.25 Million	7.00x	N/A
2023	$1.91 Billion	$46.02 Million	-$70.80 Million	41.58x	N/A
2024	$616.76 Million	$43.27 Million	-$130.87 Million	14.25x	N/A

Competitor Companies of EYPT by Market Capitalization

Companies near Eyepoint Pharmaceuticals Inc in the global market cap rankings as of November 5, 2026. Also see EYPT total asset value for a full breakdown of the balance sheet.

Key companies related to Eyepoint Pharmaceuticals Inc by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#181	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$130.90 Billion	$549.04
#373	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$76.14 Billion	$930.67
#415	CSL Ltd	AU:CSL	$67.74 Billion	AU$197.34
#503	Moderna Inc	NASDAQ:MRNA	$54.14 Billion	$258.38

Market Capitalization of Eyepoint Pharmaceuticals Inc (2015–2026)

Market capitalization of Eyepoint Pharmaceuticals Inc from 2015 to today. Between 2015 and today, Eyepoint Pharmaceuticals Inc's market cap moved from $3.99 Billion to $ 32.70 Million, with a yearly change of -34.06%.

Year	Market Cap	Change (%)
2026	$32.70 Million	-97.84%
2025	$1.51 Billion	+145.23%
2024	$616.76 Million	-67.76%
2023	$1.91 Billion	+560.29%
2022	$289.76 Million	-71.41%
2021	$1.01 Billion	+86.02%
2020	$544.74 Million	-57.55%
2019	$1.28 Billion	-17.99%
2018	$1.56 Billion	+75.00%
2017	$894.10 Million	-36.84%
2016	$1.42 Billion	-64.52%
2015	$3.99 Billion	--

End of Day Market Cap According to Different Sources

On Nov 5th, 2026 the market cap of Eyepoint Pharmaceuticals Inc was reported to be:

Source	Market Cap
Yahoo Finance	$32.70 Million USD
MoneyControl	$32.70 Million USD
MarketWatch	$32.70 Million USD
marketcap.company	$32.70 Million USD
Reuters	$32.70 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Eyepoint Pharmaceuticals Inc

NASDAQ:EYPT USA Biotechnology

Market Cap

$32.70 Million

Market Cap Rank

#23266 Global

#5090 in USA

Share Price

$0.40

Change (1 day)

-1.23%

52-Week Range

$0.35 - $18.85

All Time High

$48.20